Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Bijblijven 4/2016

01-06-2016

Het gebruik van MRI-scan bij prostaatkanker

Auteur: Dr. Stijn Heijmink

Gepubliceerd in: Bijblijven | Uitgave 4/2016

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Magnetische resonantie imaging (MRI) is een vorm van radiologische beeldvorming waarbij geen röntgenstraling maar radiofrequente golven gebruikt worden om wekedelenweefsels in het lichaam af te beelden. Het gebied van het kleine bekken, waarin zich ook de prostaat bevindt, is hiervoor uitstekend geschikt. Er wordt steeds vaker een MRI-scan verricht bij patiënten met (een verdenking op) prostaatkanker. Om inzicht te krijgen in de mogelijkheden van MRI bij prostaatkanker, is het van belang eerst enige informatie te verschaffen over de anatomie van de prostaat en de pathologie van prostaatkanker, alsook over de overige diagnostische hulpmiddelen en mogelijke therapiekeuzes.
Literatuur
2.
go back to reference McNeal JE. Normal anatomy of the prostate and changes in benign prostatic hypertrophy and carcinoma. Semin Ultrasound CT MR. 1988;9(5):329–34. PubMed McNeal JE. Normal anatomy of the prostate and changes in benign prostatic hypertrophy and carcinoma. Semin Ultrasound CT MR. 1988;9(5):329–34. PubMed
3.
go back to reference Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer. 2000;89(8):1800–9. CrossRefPubMed Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer. 2000;89(8):1800–9. CrossRefPubMed
4.
go back to reference Miller GJ, Cygan JM. Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume and capsule penetration. J Urol. 1994;152(5 Pt 2):1709–13. PubMed Miller GJ, Cygan JM. Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume and capsule penetration. J Urol. 1994;152(5 Pt 2):1709–13. PubMed
5.
go back to reference McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol. 1988;12(12):897–906. CrossRefPubMed McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol. 1988;12(12):897–906. CrossRefPubMed
6.
7.
go back to reference Egevad L, Granfors T, Karlberg L, Bergh A, Stattin P. Prognostic value of the Gleason score in prostate cancer. BJU Int. 2002;89(6):538–42. CrossRefPubMed Egevad L, Granfors T, Karlberg L, Bergh A, Stattin P. Prognostic value of the Gleason score in prostate cancer. BJU Int. 2002;89(6):538–42. CrossRefPubMed
8.
go back to reference McNeal JE, Villers AA, Redwine EA, Freiha FS, Stamey TA. Capsular penetration in prostate cancer. Significance for natural history and treatment. Am J Surg Pathol. 1990;14(3):240–7. CrossRefPubMed McNeal JE, Villers AA, Redwine EA, Freiha FS, Stamey TA. Capsular penetration in prostate cancer. Significance for natural history and treatment. Am J Surg Pathol. 1990;14(3):240–7. CrossRefPubMed
9.
go back to reference Ohori M, Scardino PT, Lapin SL, Seale-Hawkins C, Link J, Wheeler TM. The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer. Am J Surg Pathol. 1993;17(12):1252–61. CrossRefPubMed Ohori M, Scardino PT, Lapin SL, Seale-Hawkins C, Link J, Wheeler TM. The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer. Am J Surg Pathol. 1993;17(12):1252–61. CrossRefPubMed
10.
go back to reference Saitoh H, Yoshida K, Uchijima Y, Kobayashi N, Suwata J, Kamata S. Two different lymph node metastatic patterns of a prostatic cancer. Cancer. 1990;65(8):1843–6. CrossRefPubMed Saitoh H, Yoshida K, Uchijima Y, Kobayashi N, Suwata J, Kamata S. Two different lymph node metastatic patterns of a prostatic cancer. Cancer. 1990;65(8):1843–6. CrossRefPubMed
11.
go back to reference Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, et al. Metastatic patterns in adenocarcinoma. Cancer. 2006;106(7):1624–33. CrossRefPubMed Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, et al. Metastatic patterns in adenocarcinoma. Cancer. 2006;106(7):1624–33. CrossRefPubMed
12.
go back to reference Ploussard G, Epstein JI, Montironi R, Carroll PR, Wirth M, Grimm M‑O, et al. The contemporary concept of significant versus insignificant prostate cancer. Eur Urol. 2011;60(2):291–303. CrossRefPubMed Ploussard G, Epstein JI, Montironi R, Carroll PR, Wirth M, Grimm M‑O, et al. The contemporary concept of significant versus insignificant prostate cancer. Eur Urol. 2011;60(2):291–303. CrossRefPubMed
14.
go back to reference Kuriyama M, Wang MC, Papsidero LD, Killian CS, Shimano T, Valenzuela L, et al. Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res. 1980;40(12):4658–62. PubMed Kuriyama M, Wang MC, Papsidero LD, Killian CS, Shimano T, Valenzuela L, et al. Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res. 1980;40(12):4658–62. PubMed
15.
go back to reference Ellis WJ, Brawer MK. The significance of isoechoic prostatic carcinoma. J Urol. 1994;152(6 Pt 2):2304–7. PubMed Ellis WJ, Brawer MK. The significance of isoechoic prostatic carcinoma. J Urol. 1994;152(6 Pt 2):2304–7. PubMed
16.
go back to reference Gore JL, Shariat SF, Miles BJ, Kadmon D, Jiang N, Wheeler TM, et al. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol. 2001;165(5):1554–9. CrossRefPubMed Gore JL, Shariat SF, Miles BJ, Kadmon D, Jiang N, Wheeler TM, et al. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol. 2001;165(5):1554–9. CrossRefPubMed
17.
go back to reference Scherr DS, Eastham J, Ohori M, Scardino PT. Prostate biopsy techniques and indications: when, where, and how? Semin Urol Oncol. 2002;20(1):18–31. CrossRefPubMed Scherr DS, Eastham J, Ohori M, Scardino PT. Prostate biopsy techniques and indications: when, where, and how? Semin Urol Oncol. 2002;20(1):18–31. CrossRefPubMed
18.
go back to reference King CR, McNeal JE, Gill H, Presti JC. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. Int J Radiat Oncol Biol Phys. 2004;59(2):386–91. CrossRefPubMed King CR, McNeal JE, Gill H, Presti JC. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. Int J Radiat Oncol Biol Phys. 2004;59(2):386–91. CrossRefPubMed
19.
go back to reference Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol. 2011;59(4):477–94. CrossRefPubMed Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol. 2011;59(4):477–94. CrossRefPubMed
20.
go back to reference Fütterer JJ, Heijmink SWTPJ, Scheenen TWJ, Jager GJ, Hulsbergen-Van de Kaa CA, Witjes JA, et al. Prostate cancer: local staging at 3‑T endorectal MR imaging – early experience. Radiology. 2006;238(1):184–91. CrossRefPubMed Fütterer JJ, Heijmink SWTPJ, Scheenen TWJ, Jager GJ, Hulsbergen-Van de Kaa CA, Witjes JA, et al. Prostate cancer: local staging at 3‑T endorectal MR imaging – early experience. Radiology. 2006;238(1):184–91. CrossRefPubMed
21.
go back to reference Heijmink SWTPJ, Fütterer JJ, Hambrock T, Takahashi S, Scheenen TWJ, Huisman HJ, et al. Prostate cancer: body-array versus endorectal coil MR imaging at 3 T – comparison of image quality, localization, and staging performance. Radiology. 2007;244(1):184–95. CrossRefPubMed Heijmink SWTPJ, Fütterer JJ, Hambrock T, Takahashi S, Scheenen TWJ, Huisman HJ, et al. Prostate cancer: body-array versus endorectal coil MR imaging at 3 T – comparison of image quality, localization, and staging performance. Radiology. 2007;244(1):184–95. CrossRefPubMed
22.
go back to reference Hövels AM, Heesakkers RAM, Adang EM, Jager GJ, Strum S, Hoogeveen YL, et al. The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol. 2008;63(4):387–95. CrossRefPubMed Hövels AM, Heesakkers RAM, Adang EM, Jager GJ, Strum S, Hoogeveen YL, et al. The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol. 2008;63(4):387–95. CrossRefPubMed
23.
go back to reference Barrett T, Vargas HA, Akin O, Goldman DA, Hricak H. Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancer. Radiology. 2012;263(3):751–7. CrossRefPubMedPubMedCentral Barrett T, Vargas HA, Akin O, Goldman DA, Hricak H. Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancer. Radiology. 2012;263(3):751–7. CrossRefPubMedPubMedCentral
24.
go back to reference Vargas HA, Lawrence EM, Mazaheri Y, Sala E. Updates in advanced diffusion-weighted magnetic resonance imaging techniques in the evaluation of prostate cancer. World J Radiol. 2015;7(8):184–8. CrossRefPubMedPubMedCentral Vargas HA, Lawrence EM, Mazaheri Y, Sala E. Updates in advanced diffusion-weighted magnetic resonance imaging techniques in the evaluation of prostate cancer. World J Radiol. 2015;7(8):184–8. CrossRefPubMedPubMedCentral
25.
go back to reference Hambrock T, Somford DM, Huisman HJ, Oort IM van, Witjes JA, Hulsbergen-van de Kaa CA, et al. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology. 2011;259(2):453–61. CrossRefPubMed Hambrock T, Somford DM, Huisman HJ, Oort IM van, Witjes JA, Hulsbergen-van de Kaa CA, et al. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology. 2011;259(2):453–61. CrossRefPubMed
26.
go back to reference Hötker AM, Mazaheri Y, Aras Ö, Zheng J, Moskowitz CS, Gondo T, et al. Assessment of prostate cancer aggressiveness by use of the combination of quantitative DWI and dynamic contrast-enhanced MRI. AJR Am J Roentgenol. 2016;206(4):756–63. CrossRefPubMed Hötker AM, Mazaheri Y, Aras Ö, Zheng J, Moskowitz CS, Gondo T, et al. Assessment of prostate cancer aggressiveness by use of the combination of quantitative DWI and dynamic contrast-enhanced MRI. AJR Am J Roentgenol. 2016;206(4):756–63. CrossRefPubMed
27.
go back to reference Hoeks CMA, Barentsz JO, Hambrock T, Yakar D, Somford DM, Heijmink SWTPJ, et al. Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology. 2011;261(1):46–66. CrossRefPubMed Hoeks CMA, Barentsz JO, Hambrock T, Yakar D, Somford DM, Heijmink SWTPJ, et al. Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology. 2011;261(1):46–66. CrossRefPubMed
28.
go back to reference Vos EK, Kobus T, Litjens GJS, Hambrock T, Hulsbergen-van de Kaa CA, Barentsz JO, et al. Multiparametric magnetic resonance imaging for discriminating low-grade from high-grade prostate cancer. Invest Radiol. 2015;50(8):490–7. CrossRefPubMed Vos EK, Kobus T, Litjens GJS, Hambrock T, Hulsbergen-van de Kaa CA, Barentsz JO, et al. Multiparametric magnetic resonance imaging for discriminating low-grade from high-grade prostate cancer. Invest Radiol. 2015;50(8):490–7. CrossRefPubMed
29.
go back to reference Fütterer JJ, Briganti A, De Visschere P, Emberton M, Giannarini G, Kirkham A, et al. Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol. 2015;68(6):1045–53. CrossRefPubMed Fütterer JJ, Briganti A, De Visschere P, Emberton M, Giannarini G, Kirkham A, et al. Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol. 2015;68(6):1045–53. CrossRefPubMed
30.
go back to reference Thompson JE, Leeuwen PJ van, Moses D, Shnier R, Brenner P, Delprado W, et al. The diagnostic performance of multiparametric magnetic resonance imaging to detect significant prostate cancer. J Urol. 2016;195(5):1428–35. CrossRefPubMed Thompson JE, Leeuwen PJ van, Moses D, Shnier R, Brenner P, Delprado W, et al. The diagnostic performance of multiparametric magnetic resonance imaging to detect significant prostate cancer. J Urol. 2016;195(5):1428–35. CrossRefPubMed
31.
go back to reference Hoeks CMA, Hambrock T, Yakar D, Hulsbergen-van de Kaa CA, Feuth T, Witjes JA, et al. Transition zone prostate cancer: detection and localization with 3‑T multiparametric MR imaging. Radiology. 2013;266(1):207–17. CrossRefPubMed Hoeks CMA, Hambrock T, Yakar D, Hulsbergen-van de Kaa CA, Feuth T, Witjes JA, et al. Transition zone prostate cancer: detection and localization with 3‑T multiparametric MR imaging. Radiology. 2013;266(1):207–17. CrossRefPubMed
32.
go back to reference Steenbergen P, Haustermans K, Lerut E, Oyen R, De Wever L, Van den Bergh L, et al. Prostate tumor delineation using multiparametric magnetic resonance imaging: Inter-observer variability and pathology validation. Radiother Oncol. 2015;115(2):186–90. CrossRefPubMed Steenbergen P, Haustermans K, Lerut E, Oyen R, De Wever L, Van den Bergh L, et al. Prostate tumor delineation using multiparametric magnetic resonance imaging: Inter-observer variability and pathology validation. Radiother Oncol. 2015;115(2):186–90. CrossRefPubMed
33.
go back to reference Dinh CV, Steenbergen P, Ghobadi G, Heijmink SWTJP, Pos FJ, Haustermans K, et al. Magnetic resonance imaging for prostate cancer radiotherapy. Phys Med. 2016;32(3):446–51. CrossRefPubMed Dinh CV, Steenbergen P, Ghobadi G, Heijmink SWTJP, Pos FJ, Haustermans K, et al. Magnetic resonance imaging for prostate cancer radiotherapy. Phys Med. 2016;32(3):446–51. CrossRefPubMed
34.
go back to reference Scheenen TWJ, Heijmink SWTPJ, Roell SA, Hulsbergen-Van de Kaa CA, Knipscheer BC, Witjes JA, et al. Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility. Radiology. 2007;245(2):507–16. CrossRefPubMed Scheenen TWJ, Heijmink SWTPJ, Roell SA, Hulsbergen-Van de Kaa CA, Knipscheer BC, Witjes JA, et al. Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility. Radiology. 2007;245(2):507–16. CrossRefPubMed
35.
go back to reference Pondman KM, Fütterer JJ, Haken B ten, Schultze Kool LJ, Witjes JA, Hambrock T, et al. MR-guided biopsy of the prostate: an overview of techniques and a systematic review. Eur Urol. 2008;54(3):517–27. CrossRefPubMed Pondman KM, Fütterer JJ, Haken B ten, Schultze Kool LJ, Witjes JA, Hambrock T, et al. MR-guided biopsy of the prostate: an overview of techniques and a systematic review. Eur Urol. 2008;54(3):517–27. CrossRefPubMed
Metagegevens
Titel
Het gebruik van MRI-scan bij prostaatkanker
Auteur
Dr. Stijn Heijmink
Publicatiedatum
01-06-2016
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Bijblijven / Uitgave 4/2016
Print ISSN: 0168-9428
Elektronisch ISSN: 1876-4916
DOI
https://doi.org/10.1007/s12414-016-0136-3

Andere artikelen Uitgave 4/2016

Bijblijven 4/2016 Naar de uitgave